Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study

By Isik AZ   Caglar GS   Sozen E   Akarsu C   Tuncay G   Ozbıcer T   Vicdan K  

Reproductive BioMedicine Online, Vol. 19, Iss. 4, 2009-10 ,pp. : 472-477

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

GnRH antagonist in IVF poor-responder patients: results of a randomized trial

By Marci Roberto   Caserta Donatella   Dolo Vincenza   Tatone Carla   Pavan Antonio   Moscarini Massimo  

Reproductive BioMedicine Online, Vol. 11, Iss. 2, 2005-08 ,pp. : 189-193

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

A prospective randomized study comparing coasting with GnRH antagonist administration in patients at risk for severe OHSS

By Aboulghar Mohamed A   Mansour Ragaa T   Amin Yahia M   Al-Inany Hesham G   Aboulghar Mona M   Serour Gamal I  

Reproductive BioMedicine Online, Vol. 15, Iss. 3, 2007-09 ,pp. : 271-279

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Comparable effectiveness using flexible single-dose GnRH antagonist (cetrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles - a prospective, randomized study

By Vlaisavljevic Veljko   Reljic Milan   Lovrec Vida Gavric   Kovacic Borut  

Reproductive BioMedicine Online, Vol. 7, Iss. 3, 2003-10 ,pp. : 301-308

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist

By Garcia-Velasco JA   Coelingh Bennink HJT   Epifanio R   Escudero E   Pellicer A   Simón C  

Reproductive BioMedicine Online, Vol. 15, Iss. 3, 2007-09 ,pp. : 280-287

Reproductive Healthcare Ltd

Access to resources Recommend Favorite